Connecticut: Yale to Pay $308K to Resolve Violations of Controlled Substances Act

Vanessa Roberts Avery, United States Attorney for the District of Connecticut, today announced that Yale University, on behalf of Yale Medicine and the Yale Fertility Center, has entered into a civil settlement agreement with the federal government in which it will pay a total of $308,250 to resolve allegations that it violated civil provisions of the Controlled Substances Act.

The Yale Fertility Center is a fertility medical practice located on Yale University’s West Campus, in Orange, Connecticut. The Yale Fertility Center is operated by Yale Medicine, the clinical practice for the Yale School of Medicine, and a component of Yale University (collectively, “Yale”). The settlement resolves allegations that Yale failed to maintain complete and accurate records concerning the controlled substances it purchased and dispensed at the Yale Fertility Center, and failed to provide effective controls and procedures to guard against theft and diversion of controlled substances.

Read Entire Story: